[1]邹扬帆  宁浩勇 于 新.颅咽管瘤的病理特征及分子病理学研究进展[J].中国临床神经外科杂志,2020,(06):403-406.[doi:10.13798/j.issn.1009-153X.2020.06.023]
点击复制

颅咽管瘤的病理特征及分子病理学研究进展()
分享到:

《中国临床神经外科杂志》[ISSN:1009-153X/CN:42-1603/TN]

卷:
期数:
2020年06期
页码:
403-406
栏目:
综述
出版日期:
2020-06-15

文章信息/Info

文章编号:
1009-153X(2020)06-0403-04
作者:
邹扬帆  宁浩勇 于 新
310022 杭州,浙江省肿瘤医院神经外科(邹扬帆);100037 北京,解放军总医院第六医学中心神经外科(于 新),病理科(宁浩勇)
关键词:
颅咽管瘤病理特征分子病理学
分类号:
R 739.41
DOI:
10.13798/j.issn.1009-153X.2020.06.023
文献标志码:
A

参考文献/References:

[1] Louis DN, Perry A, Reifenberger G, et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary [J]. Acta Neuropathol, 2016, 131(6): 803-820.
[2] Holsken A, Sill M, Merkle J, et al. Adamantinomatous and papillary craniopharyngiomas are characterized by distinct epigenomic as well as mutational and transcriptomic profiles[J]. Acta Neuropathol Commun, 2016, 4: 20.
[3] Rushing EJ, Wesseling P. Towards an integrated morpholo-gical and molecular WHO diagnosis of central nervous system tumors: a paradigm shift [J]. Curr Opin Neurol, 2014,28: 628-632.
[4] Karavitaki N, Brufani C, Warner JT, et al. Craniopharyngio-mas in children and adults: systematic analysis of 121 cases with long-term follow-up [J]. Clin Endocrinol (Oxf), 2005, 62(4): 397-409.
[5] Barkhoudarian G, Laws ER. Craniopharyngioma: history [J]. Pituitary, 2012, 16(1): 1-8.
[6] Pascual JM, Prieto R, Rosdolsky M, et al. Cystic tumors of the pituitary infundibulum: seminal autopsy specimens (1899 to 1904) that allowed clinical-pathological cranio-pharyngioma characterization [J]. Pituitary, 2018, 21(4): 393-405.
[7] Harris BT, Horoupian DS, Tse V, et al. Melanotic cranio-pharyngioma: a report of two cases [J]. Acta Neuropatholo-gica, 1999, 98(4): 433-436.
[8] Beaty NB, Ahn E. Adamantinomatous craniopharyngioma containing teeth [J]. New Engl J Med, 2014, 370: 860-860.
[9] Bernstein ML, Buchino JJ. The histologic similarity between craniopharyngioma and odontogenic lesions: a reappraisal [J]. Oral Surg Oral Med, Oral Pathol, 1983, 56(5): 502-511.
[10] Kim MS, Kim YS, Lee HK, et al. Primary intracranial ecto-pic craniopharyngioma in a patient with probable Gardner’ssyndrome [J]. J Neurosurg, 2014, 120(2): 337-341.
[11] H?lsken A, Schwarz M, Gillmann C, et al. Characterization of the murine orthotopic adamantinomatous craniopharyn-gioma PDX model by MRI in correlation with histology [J]. PLOS ONE, 2018, 13(5): e0197895.
[12] Yang J, Hou Z, Wang C, et al. Gene expression profiles reveal key genes for early diagnosis and treatment of ada-mantinomatous craniopharyngioma [J]. Cancer Gene Ther, 2018, 25(9-10): 227-239.
[13] Campanini ML, Colli LM, Paixao BM, et al. CTNNB1 gene mutations, pituitary transcription factors, and MicroRNA expression involvement in the pathogenesis of adamantino-matous craniopharyngiomas [J]. Horm Cancer, 2010, 1(4): 187-196.
[14] Andoniadou C L, Gaston-Massuet C, Reddy R, et al. Iden-tification of novel pathways involved in the pathogenesis of human adamantinomatous craniopharyngioma [J]. Acta Neuropathol, 2012, 124(2): 259-271.
[15] Giangaspero F, Burger PC, Osborne DR, et al. Suprasellar papillary squamous epithelioma ("papillary craniopharyn-gioma") [J]. Am J Surg Pathol, 1984, 8(1): 57-64.
[16] Brastianos PK, Taylor-Weiner A, Manley PE, et al. Exome sequencing identifies BRAF mutations in papillary cranio-pharyngiomas [J]. Nat Genet, 2014, 46(2): 161-165.
[17] Brastianos P K, Shankar G M, Gill CM. Dramatic response of BRAF V600E mutant papillary craniopharyngioma to targeted therapy [J]. JNCI J Natl Cancer Inst, 2015, 108(2): djv310.
[18] Rostami E, Witt Nystr?m P, Libard S, et al. Recurrent papi-llary craniopharyngioma with BRAFV600E mutation treatedwith neoadjuvant-targeted therapy[J]. Acta Neurochir (Wien), 2017, 159(11): 2217-2221.
[19] Bao Y, Pan J, Qi ST, et al. Origin of craniopharyngiomas: implications for growth pattern, clinical characteristics, and outcomes of tumor recurrence [J]. J Neurosurg, 2016: 24-32.
[20] Zygourakis CC, Kaur G, Kunwar S, et al. Modern treatment of 84 newly diagnosed craniopharyngiomas [J]. J Clin Neurosci, 2014, 21(9): 1558-1566.
[21] Prieto R, Pascual J M, Subhi-Issa I, et al. Predictive factors for craniopharyngioma recurrence: a systematic review and illustrative case report of a rapid recurrence [J]. World Neurosurg, 2013, 79(5-6): 733-749.
[22] Ujifuku K, Matsuo T, Takeshita T, et al. Malignant transfor-mation of craniopharyngioma associated with moyamoya syndrome [J]. Neurol Med Chir (Tokyo), 2010, 50(7): 599-603.
[23] Izumoto S, Suzuki T, Kinoshita M, et al. Immunohistochemi-cal detection of female sex hormone receptors in cranio-pharyngiomas: correlation with clinical and histologic features [J]. Surg Neurol, 2005, 63(6): 520-525.
[24] Agozzino L, Ferraraccio F, Accardo M, et al. Morphological and ultrastructural findings of prognostic impact in cranio-pharyngiomas [J]. Ultrastruct Pathol, 2009, 30(3): 143-150.
[25] Proescholdt M, Merrill M, Stoerr EM, et al. Expression of carbonic anhydrase Ⅸ in craniopharyngiomas [J]. J Neuro-surg, 2011, 796-801.
[26] Hu C, Chen J, Meng Y, et al. Phosphorus-32 interstitial radiotherapy for recurrent craniopharyngioma: expressions of vascular endothelial growth factor and its receptor-2 and imaging features of tumors are associated with tumor radio-sensitivity [J]. Medicine (Baltimore), 2018, 97(26): e11136.
[27] Vidal S, Kovacs K, Lloyd RV, et al. Angiogenesis in patientswith craniopharyngiomas: correlation with treatment and outcome [J]. Cancer, 2002, 94(3): 738-745.
[28] Ebrahimi A, Honegger J, Schluesener H, et al. Osteonectin expression in surrounding stroma of craniopharyngiomas [J]. Int J Surg Pathol, 2013, 21(6): 591-598.
[29] Lubansu A, Ruchoux M M, Brotchi J, et al. Cathepsin B, D and K expression in adamantinomatous craniopharyngiomas relates to their levels of differentiation as determined by the patterns of retinoic acid receptor expression [J]. Histopatho-logy, 2003, 43(6): 563-572.
[30] Xia Z, Liu W, Li S, et al. Expression of matrix metallopro-teinase-9, type Ⅳ collagen and vascular endothelial growth factor in adamantinous craniopharyngioma [J]. Neurochem Res, 2011, 36(12): 2346-2351.
[31] Gong J, Zhang H, Xing S, et al. High expression levels of CXCL12 and CXCR4 predict recurrence of adamanti-nomatous craniopharyngiomas in children [J]. Cancer Biomark, 2014, 14(4): 241-251.

相似文献/References:

[1]葛怡宁 幸 兵 姚 勇 邓 侃 王任直.颅咽管瘤合并毛细胞星形细胞瘤1例[J].中国临床神经外科杂志,2016,(05):319.[doi:10.13798/j.issn.1009-153X.2016.05.023]
[2]王洪伟 张剑宁 于 新 王亚明 李海龙 韩铖琛 杨 帆.颅咽管瘤的个体化治疗分析[J].中国临床神经外科杂志,2016,(03):141.[doi:10.13798/j.issn.1009-153X.2016.03.003]
 WANG Hong-wei,ZHANG Jian-ning,YU Xin,et al.Individualized treatment for craniopharyngiomas and analyses of typical cases[J].,2016,(06):141.[doi:10.13798/j.issn.1009-153X.2016.03.003]
[3]程 荆 江普查 曹长军 李登辉 黄 充 游 金 兰 静.颅咽管瘤显微手术的疗效分析[J].中国临床神经外科杂志,2016,(01):1.[doi:10.13798/j.issn.1009-153X.2016.01.001]
 CHENG Jing,JIANG Pu-cha,CAO Chang-jun,et al.Analysis of curative effect of microsurgery on craniopharyngiomas (report of 126 cases)[J].,2016,(06):1.[doi:10.13798/j.issn.1009-153X.2016.01.001]
[4]项 炜 何运松 朱贤立 赵洪洋 张方成 林 洪 林 宁 林敏华.216例颅咽管瘤的显微手术治疗[J].中国临床神经外科杂志,2015,(04):205.[doi:10.13798/j.issn.1009-153X.2015.04.004]
 XIANG Wei,HE Yun-song,ZHU Xian-li,et al.Microsurgery for craniopharyngiomas (report of 216 cases)[J].,2015,(06):205.[doi:10.13798/j.issn.1009-153X.2015.04.004]
[5]李琳琳 李凤朝 刘 慧.颅骨血管瘤6例并文献复习[J].中国临床神经外科杂志,2017,(04):248.[doi:10.13798/j.issn.1009-153X.2017.04.015]
[6]毛 峰 常 隽 陈 军 唐思成 柯昌庶 王 煜.中枢神经系统原发性黑色素肿瘤的临床特征及病理特征分析[J].中国临床神经外科杂志,2017,(08):533.[doi:10.13798/j.issn.1009-153X.2017.08.003]
 MAO Feng,CHANG Jun,CHEN Jun,et al.Analysis of clinical and pathological characteristics of primary melanocytomas in central nervous system[J].,2017,(06):533.[doi:10.13798/j.issn.1009-153X.2017.08.003]
[7]晁迎九、陈 昱、高 歌、张 扬、牛朝诗、魏祥品.颅咽管瘤伴前交通动脉动脉瘤1例[J].中国临床神经外科杂志,2017,(09):672.[doi:10.13792017.09/j.issn.1009-153X.2017.09.023]
[8]陈 军 赵一清 唐思成 郑一枫 王 煜.经胼胝体-透明隔-穹窿间入路显微手术切除第三脑室内颅咽管瘤的疗效分析[J].中国临床神经外科杂志,2018,(06):395.[doi:10.13798/j.issn.1009-153X.2018.06.004]
 CHEN Jun,ZHAO Yi-qing,TANG Si-cheng,et al.Curative effect of microsurgery via transcallosal-septum pellucidum-interforniceal approach on craniopharyngiomas in the third ventricles[J].,2018,(06):395.[doi:10.13798/j.issn.1009-153X.2018.06.004]
[9]孟肖利 万经海.神经内镜下经扩大鼻蝶入路手术切除颅咽管瘤[J].中国临床神经外科杂志,2019,(05):262.[doi:10.13798/j.issn.1009-153X.2019.05.002]
 MENG Xiao-li,WAN Jing-hai.Endosope-assisted neurosurgery through extended endonasal transsphenoidal approach for craniopharyngiomas[J].,2019,(06):262.[doi:10.13798/j.issn.1009-153X.2019.05.002]

备注/Memo

备注/Memo:
(2019-01-07收稿,2019-01-28修回)通讯作者:于 新,E-mail:yuxin37@sina.cn
更新日期/Last Update: 2020-06-15